Uncategorised - European Medical Journal

ESMO 2023 Industry Sponsored Satellite Symposium: Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment with Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors

At the 2023 European Society for Medical Oncology (ESMO) Annual Congress, held in Madrid, Spain, Jürgen Wolf, University Hospital Cologne…

VPAG: the UK's ticket to pharma superpower status?

A deal ends months of wrangling between the UK government and the ABPI, but what will it mean for the industry and the UK’s bid to become a life sciences superpower?

Poor Mental Health in Patients with Atopic Dermatitis

According to new research, the chance of developing anxiety and depression is increased in patients with atopic dermatitis, mostly when additional allergic symptoms are present.

Review of the European Society for Medical Oncology (ESMO) Congress 2023

RENOWNED for its art, history, and above all, churros, Madrid, Spain, saw thousands flock to the city this October for the European Society…

Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors

The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…

Dressing for Paediatric Hypospadias

The optimal dressing is still unclear, despite hypospadias being one of the most prevalent surgical operations. Children’s dressing for…

Swiss-PO: A Web Tool for Personalised Oncology – Upcoming Updates

Next-generation sequencing techniques enable rapid detection of mutations present in a patient’s tumour. The next step is to define…

Pregnancy After Breast Cancer: Is it Safe?

AN INSIGHTFUL session featuring a debate analysed the safety and feasibility of pregnancy amongst survivors of early breast cancer (EBC) at…

Current and Upcoming Treatment Strategies After CDK4/6 Inhibitors for Patients With ER+/HER2- Advanced Breast Cancer

The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…

Reduced Diversity of HLA Class I Alleles May Contribute to the Early Manifestation of Breast Cancer in Carriers of the BRCA1 Mutation

Most female carriers of germline BRCA1 mutations develop breast and/or ovarian cancer. However, the penetrance of BRCA1 pathogenic variants…